Catalog Advanced Search

Search by Category
Search by Format
Sort By
Search by Type
Search by Category
Search in Packages
Search by Format
Search by Type
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By
  • Contains 4 Component(s), Includes Credits Includes a Live Web Event on 02/08/2023 at 2:00 PM (EST)

    The Unified Patent Court is supposed to open its doors on June 1, 2023. That means, unless opted out of the system, European patents can be enforced by litigation before this new court for multiple EPC states in one go, and European patents in force in the participating member states can become liable for revocation in a single UPC court action. With the opening of the UPC the European Patent Office will also begin granting Unitary Patents providing patent protection in the participating member states; these Unitary Patents will be administered by the EPO and can only be litigated before the UPC, resulting in one-stop-shops for both administration and litigation. Speakers will provide an overview of the UPC system and shed some more light on the threats and opportunities of this new venue.

    The Unified Patent Court is supposed to open its doors on June 1, 2023. That means, unless opted out of the system, European patents can be enforced by litigation before this new court for multiple EPC states in one go, and European patents in force in the participating member states can become liable for revocation in a single UPC court action. With the opening of the UPC the European Patent Office will also begin granting Unitary Patents providing patent protection in the participating member states; these Unitary Patents will be administered by the EPO and can only be litigated before the UPC, resulting in one-stop-shops for both administration and litigation. Speakers will provide an overview of the UPC system and shed some more light on the threats and opportunities of this new venue. Topics will include:

    • Structure of the Court
    • Litigation timelines and costs
    • Costs and benefits of Unitary Patents 
    • Strategic considerations for opting out European patents from the jurisdiction of the court

    Dr. Antje Brambrink

    Counsel

    Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

    Dr. Antje Brambrink is an attorney-at-law (Counsel) at Finnegan, Henderson, Farabow, Garrett & Dunner in Munich. As patent litigator Antje advises and represents clients in complex, often cross-border patent disputes. She regularly acts before all German patent courts, including infringement, inspection, compulsory license and nullity proceedings at the Federal Patent Court and the Federal Supreme Court. Her expertise covers a wide range of industries and technologies, including high-tech, renewable energies and in particular life sciences, where she benefits from her dual qualification as dentist with a Ph.D. in pharmacology.

    Jakob Kellenberger

    Senior Director and Associate General Counsel

    Procter & Gamble

    Jakob Kellenberger is a Senior Director and Associate General Counsel for Procter & Gamble in Belgium. In this position, Mr. Kellenberger is responsible for P&G’s Global Home Care- and European Fabric Care-IP. He oversees a group of Patent Professionals located in P&G’s Newcastle, Schwalbach and Brussels Innovation Centers and advises Procter & Gamble’s senior management on intellectual property issues. Mr. Kellenberger has authored numerous P&G patents and patent applications, has led a number of oppositions/appeals and hearings in the EPO, has been involved in license agreements, acquisitions and divestitures, in mediation and in IP litigation. Mr. Kellenberger holds a MSc with a focus on Molecular Biology from the Swiss Federal Institute of Technology (Eidg. Tech. Hochschule - ETH) in Zürich and a Postgraduate degree in IP law from the same school. He is a Qualified Representative before the EPO, and has over 25 years of experience in IP.

    Leo Steenbeek

    Principal IP Counsel

    Koninklijke Philips N.V.

    Leo Steenbeek (LLM, MSc) is Principal IP Counsel at Philips, and is registered as a European and Dutch patent attorney. 

  • Contains 3 Component(s) Includes a Live Web Event on 01/31/2023 at 2:00 PM (EST)

    Diversity & Inclusion has become a key initiative in most corporate environments, but innovation and accountability has distinguished organizations as they progress in the space. What makes these programs you read about so successful? How can companies build an authentic program that achieves heightened goals each year when hiring and retaining talent is so challenging post-pandemic? What standards should exist for company vendors, legal and otherwise? In this panel, we will discuss those questions and more to provide a solution-based program, leaving you with some best practices as you continue in your DEI journey in 2023.

    Diversity & Inclusion has become a key initiative in most corporate environments, but innovation and accountability has distinguished organizations as they progress in the space. What makes these programs you read about so successful? How can companies build an authentic program that achieves heightened goals each year when hiring and retaining talent is so challenging post-pandemic? What standards should exist for company vendors, legal and otherwise? In this panel, we will discuss those questions and more to provide a solution-based program, leaving you with some best practices as you continue in your DEI journey in 2023. 

    Karen Cochran

    Chief IP Counsel

    Shell USA, Inc.

    Karen Cochran is the chief IP counsel at Shell, leading the company’s global IP department in support of IP strategies and related licensing activities. Karen began her career as a chemist at Rhône-Poulenc Rorer, and Merck Pharmaceuticals. Following law school, she reentered the pharmaceutical industry as a patent attorney and later joined AstraZeneca Pharmaceuticals. Karen assumed roles of increasing responsibility while with AstraZeneca, including head of Neuroscience IP, leading a global team from the company’s Swedish offices. Karen subsequently joined DuPont in 2012 where she led both IP and commercial legal teams prior to becoming DuPont’s chief IP counsel and head of IP Litigation. She is a member of IPO’s Board of Directors, serving as president. Karen has also served on the board of Association for Women in Science (AWIS), an organization committed to the advancement of women in STEM.

    Lloyd Freeman

    Chief Diversity & Inclusion Officer

    Buchanan Ingersoll & Rooney PC

    As Buchanan’s Chief Diversity & Inclusion Officer, Lloyd Freeman is responsible for advancing and expanding diversity throughout the firm and across the legal industry as a whole. Lloyd develops and drives the firm’s diversity initiatives related to attorney hiring, retention and advancement. He oversees the firm’s Diversity & Inclusion Council and promotes equitable policies, mentorship and sponsorship as key retention initiatives.  Through the use of data & analytics, Lloyd identifies potential risk areas and centers intentionality and accountability to drive meaningful impact.  Lloyd also works to ensure that the firm continues to be a driver of diversity and inclusion in the communities in which it serves. Some of these initiatives include the firm's supplier diversity program, corporate share program as well as key partnerships with local nonprofits dedicated to promoting all dimensions of diversity.  Additionally, he collaborates with Buchanan’s clients to meet and advance their diversity and inclusion goals and coordinates partnerships for mutually-beneficial programs such as internships, thought leadership, speaking engagements and more. Lloyd is also involved in nurturing key partnerships to drive strategic diversity and inclusion marketing, as well as business development initiatives.  

    Kaveh Rashidi-Yazd

    Vice President and Chief Counsel for Digital, Innovation and Technology

    Eaton Corporation

    Kaveh Rashidi-Yazd is Vice President and Chief Counsel for Digital, Innovation, IP, and Technology for Eaton Corporation. He currently leads the legal teams associated with IP, cybersecurity, data protection and privacy, and digital.  In his career, he has counseled on all aspects of IP, with expertise in developing strategies and focusing on protection, defense, exploitation, and transactional activities.  Before joining Eaton, he was Head of the U.S. IP Department and Division IP Counsel at Siemens Energy, and before going in-house, Kaveh was a senior associate in the IP practice group of Troutman Sanders, LLP (n/k/a Troutman Pepper).  Kaveh earned his Bachelor of Science in Electrical Engineering from the University of South Carolina, and his Juris Doctorate from the Franklin Pierce Law Center (n/k/a University of New Hampshire School of Law).  Within IPO, he is now a member of the Board of Directors, and a former Co-Chair of the Leadership Development Committee (2020-2022) and former Chair of the U.S. Patent Office Practice Committee (2014-2019). 

    Richard Watkins

    Sr. Principal Legal Counsel

    Medtronic

    Richard Watkins is a senior principal legal counsel at Medtronic and has practiced IP Law for 20 years. He holds a BS in Chemistry from Morehouse College and a law degree from Georgetown University. Prior to Medtronic, Richard spent time in private practice and corporate in house positions in Philadelphia, Chicago, and Memphis. He has been active in the IPO Diversity and Inclusion committee and is currently serving as the Co-Chair of the Black IP Professionals in IPO.

     

  • Contains 5 Component(s), Includes Credits

    A panel of highly experienced PTAB advocates will discuss some of the most significant developments in PTAB practice in 2022 and how those developments will impact future cases. They will discuss important precedent promulgated last year, and we will also hear about Director Vidal’s impact on the PTAB during 2022, including a summary of those cases where Director Review was granted. In this discussion, you will hear what you need to know to keep your PTAB practice sharp in 2023.

    A panel of highly experienced PTAB advocates will discuss some of the most significant developments in PTAB practice in 2022 and how those developments will impact future cases. They will discuss important precedent promulgated last year, and we will also hear about Director Vidal’s impact on the PTAB during 2022, including a summary of those cases where Director Review was granted. In this discussion, you will hear what you need to know to keep your PTAB practice sharp in 2023.

    Joshua Goldberg

    Partner

    Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

    Joshua Goldberg, leader of Finnegan’s PTAB trials section, focuses on inter partes review (IPR), covered business method (CBM), and post-grant review (PGR) proceedings before the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office (USPTO), and on ensuing appeals to the U.S. Court of Appeals for the Federal Circuit.

    Sydney Kestle

    Partner

    Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

    Sydney Kestle focuses on several areas of patent law, including pre-litigation due diligence, client counseling, litigation in U.S. district courts, and proceedings before the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office (USPTO). Her patent practice covers several technology sectors in the mechanical and electrical arts, including industrial manufacturing, medical devices, and wireless communications and related consumer products. 

    Gracie Mills

    Associate

    Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

    Gracie Mills is an associate with Finnegan where she focuses her practice on patent litigation before the Patent Trial and Appeal Board (PTAB), federal district courts, and the Court of Appeals for the Federal Circuit. Before the PTAB, she has experience representing both petitioners and patent owners, and she regularly navigates issues specific to the interplay between PTAB and federal district court litigation.

    Trenton Ward

    Partner

    Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

    Trenton Ward is a partner and patent litigator at Finnegan. Ward joined Finnegan in 2017 from the PTAB where he spent three years as a Lead Administrative Patent Judge. He served on panels for more than 275 Decisions on Institution and Final Written Decisions, authoring many. Trenton assisted the Chief Judge in formulating and executing policy for AIA trials and PTAB operations. Earlier he worked as an electrical engineer. 

    Tom Irving

    Partner

    Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

    Tom Irving is a partner with Finnegan. He has more than 40 years of experience in the field of intellectual property law. His practice includes America Invents Act (AIA) post-grant proceedings, due diligence, counseling, patent prosecution, and reissue and reexamination. He counsels clients on a wide range of mainly pharmaceutical matters, including pre-litigation, Orange Book listings of patents covering FDA-approved drugs, infringement issues, enforceability and validity analysis.

  • Contains 5 Component(s), Includes Credits

    This webinar will provide a roundup of this year’s most significant intellectual property cases. Our panelists are three litigators in private practice, all members of IPO’s Amicus Brief Committee. They will review the most significant decisions as of 2022 and give a sneak peek at coming attractions.

    2022 was an active year for IP cases. Our panelists are three litigators in private practice, all members of IPO’s Amicus Brief Committee. They will review the most significant decisions as of 2022 and give a sneak peek at coming attractions.

    On the patent side of things, the Supreme Court has granted certiorari in Amgen v. Sanofi taking up the issue of enablement. While this case involves the biopharma industry, what constitutes proper enablement cuts across all technologies, and the Supreme Court’s decision may shed light on the written description requirement as well. As to Section 101, the Supreme Court took a step back from this issue by denying certiorari in American Axle, notwithstanding the recommendation of the Solicitor General. The panel will review the relative lack of predictability that continues as a result regarding patent eligibility. And last, but certainly not least, the panel will explore the changes being wrought by the Vidal administration at the USPTO.

    On the trademark side, the Supreme Court has granted cert on two cases- Abitron Austria GmbH v. Hetronic International, and VIP Prod. LLC v. Jack Daniel's Properties, Inc., with Abitron addressing the extent of the extraterritorial reach of the Lanham Act, and Jack Daniels considering what commercial products should be considered “expressive works” to invoke free speech protections in a trademark action. Other 2022 decisions raised fascinating issues, including how trademark law is applied in the context of nonfungible token (NFT) technology.

    Paul Berghoff

    Founder

    McDonnell Boehnen Hulbert & Berghoff LLP

    Paul Berghoff, founder of McDonnell Boehnen Hulbert Berghoff LLP, has three decades of experience as lead trial counsel in complex patent litigation – both jury and bench trials and PTAB proceedings – concentrating in litigation involving pharmaceuticals, medical devices, biotechnology, electronics, and software. He has successfully tried scores of patent cases and has successfully argued dozens of times before he US Court of Appeals for the Federal Circuit. He services as Chair of the firm’s Litigation & Appeals Practice Group.  He is Vice-Chair of IPO’s Amicus Brief Committee.

    Gregory Castanias

    Partner

    Jones Day

    Greg Castanias is a partner at Jones Day in Washington, DC. He is head of the firm’s Federal Circuit team and has almost 30 years’ experience as a leading appellate and intellectual property litigator. His experience includes five US Supreme Court arguments, 70+ Federal Circuit arguments, and countless others in federal and state courts across the nation, from Alaska to Connecticut. His intellectual property experience includes such diverse technologies as genetics, diagnostics, pharmaceuticals, chemistry, electronics, and mechanical fields, as well as copyright, trademark, and trade secret disputes. He is Vice-Chair of IPO’s Amicus Brief Committee.

    Wendy Larson

    Member

    Pirkey Barber

    Wendy Larson practices trademark law with a focus on litigation. She focuses specifically on issues relating to the internet, including cybersquatting and brand protection challenges involving social media platforms and smartphone applications, keyword advertising, service provider liability, and personal jurisdiction relating to foreign online actors. She practices in federal court, before the Patent and Trademark Office’s Trademark Trial and Appeal Board (TTAB), and with dispute resolution service providers such as the Forum and the World Intellectual Property Organization (WIPO) handling domain name disputes under ICANN’s domain name dispute resolution policies. Wendy also assists clients in a variety of prosecution and other litigation matters. Wendy is a member of IPO’s Amicus Brief Committee.

  • Contains 8 Component(s), Includes Credits Recorded On: 12/15/2022

    Patent Center, which currently is being rolled out by the USPTO, will soon become the platform for all patent-related submissions. Panelists will discuss what Patent Center is, the platforms being replaced, and the various features of Patent Center. Panelists will discuss the new DOCX patent filing requirements, the related pros and cons, and offer best practice tips associated with DOCX filings.

    Patent Center, which currently is being rolled out by the USPTO, will soon become the platform for all patent-related submissions. Panelists will discuss what Patent Center is, the platforms being replaced, and the various features of Patent Center. Panelists will discuss the new DOCX patent filing requirements, the related pros and cons, and offer best practice tips associated with DOCX filings.

    *This webinar is webinar sponsored by Schwegman Lundberg & Woessner

    Bradley Forrest

    Chairman and General Counsel

    Schwegman Lundberg & Woessner

    Brad Forrest is the Chairman and General Counsel for Schwegman Lundberg & Woessner. He enjoys connecting with inventors and discussing complex technologies and sharing in inventors’ passion for their inventions. Brad also drafts and prosecutes patent applications in diverse technologies, including cloud-based computing, AI and machine learning, nanotechnology, apps, applications, operating systems, disk drives, memories, optical networks, optical ring resonators, WiFi, semiconductor, CVD Diamond, and many other technologies. Prior to becoming a patent attorney, Brad worked part-time for Honeywell International, Inc. creating computer simulations while obtaining EE and Law Degrees from the University of Minnesota. From 1984-1993, Brad worked at IBM in Rochester, Minnesota, as Counsel and Manager of the Intellectual Property Law Department, identifying several key inventions and wrote many important patents, including the RAID V patent, magneto-optic recording patents, operating system patents, distributed computing patents, networking patents, and basic patents covering server driven work processing, known as IPC. From 1994-1995, Brad was a Division Counsel and the Copyright and Trademark Counsel for IBM in New York.

    Kasie Grover

    Paralegal

    Schwegman Lundberg & Woessner

    Kasie Grover has been a paralegal at Schwegman since 2015, assisting with PCT and USPTO filings. During her time at Schwegman, Kasie’s work has predominantly included working with clients outside of the United States to obtain U.S. patents. She also serves on University client teams, and teams relating to pharmaceutical drugs, mechanical engineering and software. Prior to starting as a paralegal at Schwegman, Kasie was a case manager for two years, where she served on many of the same client teams.

    Richard Seidel

    Deputy Commissioner for Patents

    U.S. Patent and Trademark Office

    Richard Seidel is the Deputy Commissioner for Patents at the U.S. Patent and Trademark Office. During the past 25 years, Mr. Seidel has held a variety of management and leadership positions at the USPTO.  Currently, as Deputy Commissioner for Patents, he provides executive oversight over patent-examining functions in Technology Centers 1700 and 2800. These technologies include chemical and material engineering, semiconductors, memory, optical systems and components, photocopying, electrical circuits and system, printing, and measuring and testing.  Additionally, Mr. Seidel serves as the focal point for the newly created organizations of Information Technology for Patents (OITP) and Application Processing for Patents (OAPP). Mr. Seidel received his undergraduate degree in metallurgy from the Pennsylvania State University, and a Certificate in Advanced Public Management from the Maxwell School of Citizenship and Public Affairs at Syracuse University. 

  • Contains 9 Component(s), Includes Credits

    Our panel of IP operations and technology veterans will provide an overview of the evolving technical and service landscapes and introduce you to new, cutting-edge solutions to simplify your IP back office that are increasing accuracy and efficiency while simultaneously reducing cost, headcount, and risk.

    IP operations, and your reputation, depend on absolute accuracy regarding tasks such as docketing, reminders, and reporting. However, human processes are inherently error prone and the knowledge and skill are very siloed within small groups. This has necessitated significant investments in technology and human redundancy. These approaches are becoming inadequate with demands for speed and downward cost pressures.  For example, most corporate, law firm, and outsourcing group collaborative efforts are still dependent on email and human action in response thereto. Modern advances in intellectual property management systems, automation, and outsourcing are providing more robust solutions, but the new technologies and automation services introduce entirely new vocabularies, technical complexities, and new risks. Our panel of IP operations and technology veterans will provide an overview of the evolving technical and service landscapes and introduce you to new, cutting-edge solutions to simplify your IP back office that are increasing accuracy and efficiency while simultaneously reducing cost, headcount, and risk.

    *This webinar is webinar sponsored by Schwegman Lundberg & Woessner

    Mehrdad Assadi

    Chief Technology Officer

    Patrix IP Helpware

    Mehrdad Assadi - CTO at Patrix IP Helpware, providing highly configurable and adaptable IPM software solution and cost-effective Renewal and Annuity services to its global client base since the early 1990’s, with offices in US and Europe. After completing the Military Academy and graduating as Officer and end of cold war, Mehrdad decided to move over to the private sector to join Patrix at its inception.  Using his background in Computer Science to manage digitalization projects of national Trademark and Patent data, he has transitioned to developing Patrix software solution strategies over the last 20 years, focusing on providing versatile and open solutions to its customers.

    Steven Lundberg

    Founding Partner & Patent Attorney

    Schwegman Lundberg & Woessner

    Steven W. Lundberg is a registered patent attorney and a founding partner of Schwegman Lundberg & Woessner. He works with entrepreneurs, Fortune 100 companies, and a wide range in between, providing practical legal counseling and time-tested IP strategies. Steve received his B.S.E.E. from the University of Minnesota, and his law degree from William Mitchell College of Law. He has published and spoken widely on software and electronic patent protection.

    Thomas Marlow

    Chief Technology Officer & Patent Attorney

    Black Hills IP

    Thomas G. Marlow serves as CTO for Black Hills IP and President of Black Hills IP Renewals, managing the development of technical and process based solutions to improve the handling of intellectual property.  Mr. Marlow is a registered Patent Attorney with experience in both private practice prosecution and corporate in-house management.  Previously Thomas served as Director of Intellectual Property at Fairchild Semiconductor, managing worldwide product line and business unit patent strategy, enforcement, and procurement. Early career private practice patent work included prosecution and analysis of technologies in the electronic arts, including semiconductors, integrated circuit design and fabrication, wireless communications, and computer networks.

  • Contains 7 Component(s), Includes Credits Recorded On: 12/09/2022

    This presentation will focus on just a few ways that analytics are helping patent practitioners become both more efficient and more effective – and do so in the context of practitioners’ ethical responsibility to be knowledgeable about the benefits and risks associated with relevant technology. *This webinar is sponsored by LexisNexis *IPO will apply for CLE Ethics credit for this course

    Effectiveness means getting the right answer. Efficiency is getting results quicker. A patent practitioner should strive to be both effective and efficient – as those two concepts are complimentary. In other words, getting the right result but taking a long time is not ideal. And, certainly, doing a task quickly but arriving at the wrong answer is unacceptable. And this is where the right analytics can make a huge difference – as analytics are designed to enable a practitioner to get the correct result quickly. Analytics have already made an impact in other professions (e.g. sports) as well as in some areas of the legal profession. Accordingly, today’s patent practitioner should become knowledgeable about how analytics can assist his/her practice – as well as his/her client or employer. This presentation will focus on just a few ways that analytics are helping patent practitioners become both more efficient and more effective – and do so in the context of practitioners’ ethical responsibility to be knowledgeable about the benefits and risks associated with relevant technology.

    *This webinar is sponsored by LexisNexis *IPO will apply for CLE Ethics credit for this course

    David Dilenschneider

    Client Relations Consultant

    LexisNexis

    As a Client Relations Consultant, David Dilenschneider not only monitors the legal industry to identify trends and potential future developments but also consults with firms and corporations across the country to discuss their challenges and needs. David is a nationally-known speaker who has conducted over 2,800 presentations to over tens of thousands of attendees across the country – including presentations to almost every firm in the Am Law 100. David has also presented at programs offered by the National Institute for Trial Advocacy and has served as a speaker or moderator at prominent legal-education conferences, at bar association meetings, and at law schools. Internationally, David spoke on the topic of the Democratization of Knowledge and the Role of Electronic Legal Research at a conference held at the National Law University, Delhi (India). He also writes frequently about the utilization of electronic resources in the practice of law.

  • Contains 9 Component(s), Includes Credits

    This webinar will address how AIA proceedings impact Life Sciences patents. A review of PTAB statistics pertaining to Life Sciences patents will be provided and compared against other industries. The panel will discuss the impact of AIA proceedings on parallel Hatch Waxman litigation and BPCIA litigation. Speakers will also discuss the advantages and disadvantages of AIA proceedings, and debate ways that the proceedings could be improved to address industry concerns.

    This webinar will address how AIA proceedings impact Life Sciences patents. A review of PTAB statistics pertaining to Life Sciences patents will be provided and compared against other industries. The panel will discuss the impact of AIA proceedings on parallel Hatch Waxman litigation and BPCIA litigation. Speakers will also discuss the advantages and disadvantages of AIA proceedings, and debate ways that the proceedings could be improved to address industry concerns.

    Ashita Doshi

    IP Counsel Leader for IP Disputes

    Thermo Fisher Scientific

    Ashita Doshi is an IP Counsel Leader at Thermo Fisher Scientific, specializing in strategic patent dispute resolution, risk management and prosecution, with a focus on AIA patent challenges at the PTAB.  Ashita obtained a Ph.D. in Molecular Biology at Tufts University and a J.D. from the University of California at Berkeley.  She has successfully challenged about 20 patents asserted in four litigations through inter partes and ex parte reexamination, and five patents asserted in three litigations through inter partes review.  She has extensive in-house experience in litigation support, freedom-to-operate analysis, strategic product design and clearance, patent drafting and prosecution.  Her prior law firm experience includes providing non-infringement and invalidity opinions, freedom-to-operate assessments and patent landscaping; drafting and prosecuting applications; and supporting interferences, oppositions and litigations.

    Emily Johnson

    Head of IP Policy & Advocacy

    Amgen, Inc.

    Emily Johnson is Senior Counsel, IP Litigation at Amgen, one of the world’s most innovative biotechnology companies. Emily oversees Amgen’s U.S. and foreign patent litigations and post-grant proceedings before the Patent Trial and Appeal Board and she provides counsel regarding Amgen’s intellectual property strategies.  Before joining Amgen, she represented clients in private practice, litigating nearly 100 intellectual property disputes in both judicial and administrative tribunals.  Emily had the privilege of clerking for the Honorable Arthur Gajarsa at the Federal Circuit.  Emily co-chairs the PTAB Committee of the Federal Circuit Bar Association and chairs the U.S. Post-Grant Patent Office Practice Committee of Intellectual Property Owners Association.

    Philip Johnson

    Chair, Steering Committee

    Coalition for 21st Century Patent Reform

    Phil Johnson is retired as Senior Vice President – Intellectual Property Policy & Strategy of Johnson & Johnson – Law Department. Prior to April of 2014, he was Senior Vice President and Chief Intellectual Property Counsel of Johnson & Johnson where he managed a worldwide group of about 270 IP professionals, of whom over 100 were patent and trademark attorneys. Before joining Johnson & Johnson in 2000, Phil was a senior partner and co-chair of IP litigation at Woodcock Washburn in Philadelphia. During his 27 years in private practice, Phil counseled independent inventors, startups, universities and businesses of all sizes in all aspects of intellectual property law. His diverse practice pertained to advances in a wide variety of technologies, including pharmaceuticals, diagnostics, medical devices, consumer products, semi-conductor fabrication, automated manufacturing, materials and waste management. During his time in private practice, Phil served as trial counsel in countless IP disputes, including cases resolved by arbitration, bench trials, jury trials and appeals to the Federal Circuit Court of Appeals, many of which resulted in reported decisions.

    Todd Walters

    Shareholder

    Buchanan Ingersoll & Rooney PC

    Todd Walters is the Chair of the firm’s Patent Office Litigation practice and Co-Chair of the Intellectual Property section. He is a current Vice-Chair of the Post-Grant Practice Committee of the Intellectual Property Owners Association (IPO), a past Chair of the Patent Trial and Appeal Board (PTAB) Trial Committee of the American Intellectual Property Law Association (AIPLA) and a past Chair of the USPTO Post Grant and Inter Partes Practice Committee of the American Bar Association-Intellectual Property Law (ABA-IPL) section. Todd was named the Best Lawyers ® 2020 Patent Law “Lawyer of the Year” in Washington, D.C. 

  • Contains 9 Component(s), Includes Credits

    Our panel of distinguished inhouse counsel, Larry Coury, Stephanie Donahue, Henry Hadad, and Stuart Watt, moderated by experienced trial counsel, Paul Berghoff, will guide us through the issues and arguments concerning the current state of enablement and written description law and where the law may be headed.

    For the first time since the founding of the Federal Circuit, the Supreme Court will be taking a close look at Section 112.  The Supreme Court has granted certiorari in Amgen v. Sanofi on the following question: Whether enablement is governed by the statutory requirement that the specification teach those skilled in the art to “make and use” the claimed invention, 35 U.S.C. §112, or whether it must instead enable those skilled in the art “to reach the full scope of claimed embodiments” without undue experimentation—i.e., to cumulatively identify and make all or nearly all embodiments of the invention without substantial “time and effort.” And while the Supreme Court denied certiorari in a closely watched written description case, Juno v. Kite, the law of written description could very well be affected by what the Supreme Court does in Amgen. Our panel of distinguished inhouse counsel, Larry Coury, Stephanie Donahue, Henry Hadad, and Stuart Watt, moderated by experienced trial counsel, Paul Berghoff, will guide us through the issues and arguments concerning the current state of enablement and written description law and where the law may be headed.

    Paul Berghoff

    Founder

    McDonnell Boehnen Hulbert & Berghoff LLP

    Paul Berghoff, founder of McDonnell Boehnen Hulbert Berghoff LLP, has three decades of experience as lead trial counsel in complex patent litigation – both jury and bench trials and PTAB proceedings – concentrating in litigation involving pharmaceuticals, medical devices, biotechnology, electronics, and software. He has successfully tried scores of patent cases and has successfully argued dozens of times before he US Court of Appeals for the Federal Circuit. He services as Chair of the firm’s Litigation & Appeals Practice Group.  He is Vice-Chair of IPO’s Amicus Brief Committee.

    Larry Coury

    Vice President, Head of Litigation and Associate General Counsel

    Regeneron Pharmaceuticals, Inc.

    Larry Coury is Vice President, Head of Litigation and Associate General Counsel at Regeneron Pharmaceuticals, Inc. in Tarrytown, NY.  Larry oversees all of Regeneron’s litigation matters, including patent matters, and he is a registered patent attorney.  Prior to joining Regeneron, Larry was in private practice at Fish & Neave, Paul Weiss, and Cravath.  Larry received his Ph.D. in Biophysics from Harvard University, and his J.D. from Fordham Law School. 

    Stephanie Donahue

    Principal Counsel, Global Patent Litigation

    Sanofi

    Stephanie Donahue is global in-house patent litigation counsel at Sanofi. She is responsible for managing patent infringement litigation brought by and against Sanofi around the world. In that role, among other things, she develops and executes strategic patent infringement litigation action plans, negotiates patent infringement settlements, and communicates case developments and litigation risks to senior management.  Prior to joining Sanofi in 2014, Stephanie practiced at various law firms for over 10 years. She was Counsel at Vinson & Elkins LLP and an associate at Fitzpatrick, Cella, Harper & Scinto (now Venable LLP). 

    Henry Hadad

    Senior Vice President, Innovation Law

    Bristol-Meyers Squibb Company

    Henry Hadad is Senior Vice President and Deputy General Counsel at Bristol-Myers Squibb in Princeton, NJ, where he is Chief Intellectual Property Counsel, as well as lead counsel to Research & Early Development. He was also Chief IP Counsel at Schering-Plough Corporation, and held prior roles at Johnson & Johnson and in private practice. Henry is a member of numerous IP organizations, and is a past president of Intellectual Property Owners Association. He holds a B.S. in Biology from Haverford College and a J.D., cum laude, from the American University, Washington College of Law. 

    Stuart Watt

    Vice President, Law & Intellectual Property Officer

    Amgen, Inc.

    Stuart Watt is Vice President of Law and Intellectual Property Officer of Amgen Inc. and leads a group of 45 patent attorneys responsible for patent strategy, filing and prosecution of patent applications in the U.S. and foreign countries, patent litigation, and patent licensing.  Mr. Watt has actively represented Amgen in patent litigation in the U.S. and various countries around the world. He joined Amgen in 1992.  Prior to that time, he was associated with the patent law firm of Richards, Medlock & Andrews (now Sidley & Austin) in Dallas, Texas. Mr. Watt is a graduate of Brigham Young University (B.S.Ch.E.) and the University of Washington School of Law (J.D.).

  • Contains 10 Component(s), Includes Credits

    Join speakers from IPO’s Anticounterfeiting & Antipiracy and AI & New Emerging Technologies Committees to hear about developments related to AI and Effective Enforcement. In addition to demystifying the technology, the panel will discuss how AI and machine learning has revolutionized IP enforcement in the online environment—for example through platforms incorporating AI that assist in identifying online sales of counterfeit products. The panel will also provide brand owner, patent practitioner, and legislative perspectives on AI & machine learning.

    Join speakers from IPO’s Anticounterfeiting & Antipiracy and AI & New Emerging Technologies Committees to hear about developments related to AI and Effective Enforcement. Topics to be covered will include: 

    -how rights owners often lack clarity/understanding about AI and ML when embarking on a brand and/or content protection program
    - explaining “how” it works and “why” it is crucial to any technology driven program
    - intelligent “prioritization” of the (millions of) data points that programs typically involve so that rights owners can tackle the most potent threats and allocate resource appropriately)
    - demystifying AI and ML 
    -the legal aspects of AI and ML 
    -common practical challenges (relevance over volume) and practical tips for how to get the most out of an AI/ML driven program.

    Sumon Dasgupta

    Principal

    Jordan IP Law

    Sumon Dasgupta, a principal of Jordan IP Law, is involved in all aspects of patent law, including patent counseling and portfolio management across different countries and jurisdictions. Sumon has worked with a variety of clients, from solo inventors to Fortune 500 Companies. He has experience in patent enforcement, strategic patent portfolio development, trademarks, and  opinions. Sumon has presented on patent law topics for prestigious organizations, such as the Intellectual Property Owners Association (IPO) Practicing Law Institute Webinar (CLE credits earned for attendees). Sumon is an active member of IPO and is a member of the artificial intelligence (AI) and Emerging Technologies Committee. Sumon is a co-lead author of the AI Patents – Best Practices (White Paper), Intellectual Property Owners Association (published February 2022). Sumon practices in all areas of patent law, with an emphasis on preparing and prosecuting patents in the electrical, mechanical, and computer (software and hardware) arts, including neural networks, virtual reality systems, compilers, encryption systems, network systems, cloud-based systems, semiconductor manufacture and design, vehicle based systems, and graphical interfaces. 

    Tim Golder

    Partner

    Allens

    Tim Golder has more than 38 years' experience in intellectual property law. Tim is a highly experienced adviser on copyright, designs, confidential information and trade marks, as well as trade practices issues dealing with misleading and deceptive conduct. He is adept at drafting licensing, distribution and franchising agreements. He also undertakes substantial work in registering and protecting trade marks, designs and domain names. Tim has a substantial litigation practice in the intellectual property field, enforcing the rights of clients including before the Courts.

    Helen Saunders

    VP Product, Brand Protection

    Corsearch

    Helen Saunders has been working in IP protection for the last 14 years. She has a background combining law, technology, and investigations, both online and offline. She is currently VP Product, Brand Protection at Corsearch, and was formerly Chief Product Officer at Incopro, prior to acquisition by Corsearch in June 2021. During her career, Helen has worked in law enforcement, trade associations and the private sector, analysing and investigating a spectrum of online illegal activity. During her career, Helen has developed her technical skills giving her an excellent understanding of internet technologies and the opportunities created for both illegal and legal uses.  She is passionate about using data to understand online and offline challenges and using combined technology and human expertise to solve them. Helen holds a Bachelor’s in Law and a Master's in Computer and Communication Law from Queen Mary, University of London.

    Michael Sweeney

    Director and Senior Legal Counsel

    Corsearch

    Mike Sweeney is Director and Senior Legal Counsel with Corsearch based in London. As an experienced attorney, Mike counsels brands on all aspects of brand and content protection in the digital space, with a particular focus on leveraging data-driven technology to combat counterfeiting. Mike has many years of experience representing major brands in cross-border litigation in both domestic and international Courts.  More recently, Mike has been focused on leading global anti-counterfeiting and anti-piracy programs for major international brands.  

    Kenya Williams

    Trademark Enforcement Counsel

    Thermo Fisher Scientific Inc.

    Kenya L. Williams has been practicing intellectual property law for over a decade and currently serves as Trademark Enforcement Counsel for Thermo Fisher Scientific Inc. At Thermo Fisher, Kenya is responsible for the protection and enforcement of the company’s worldwide trademark portfolio covering its innovative technologies and industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Gibco, and PPD. Kenya also handles copyright and domain name matters and works cross-functionally with colleagues around the world to enforce Thermo Fisher’s intellectual property rights. 

    Prior to joining Thermo Fisher, Kenya was a trademark attorney in the Los Angeles office of Arent Fox, now ArentFox Schiff, where she was responsible for trademark enforcement and counseling in the retail, automotive, and fashion industries.